April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
A Rare De Novo Nonsense Mutation in Otx2 Causes Early Onset Rod-Cone Dystrophy and Pituitary Dysfunction
Author Affiliations & Notes
  • R. H. Henderson
    Molecular Genetics, Institute of Ophthalmology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • K. A. Williamson
    Medical Research Council Human Genetics Unit, Edinburgh, United Kingdom
  • J. Kennedy
    Medical Research Council Human Genetics Unit, Edinburgh, United Kingdom
  • A. G. Robson
    Clinical Electrophysiology,
    Moorfields Eye Hospital, London, United Kingdom
  • G. E. Holder
    Clinical Electrophysiology,
    Moorfields Eye Hospital, London, United Kingdom
  • D. R. FitzPatrick
    Medical Research Council Human Genetics Unit, Edinburgh, United Kingdom
  • V. van Heyningen
    Medical Research Council Human Genetics Unit, Edinburgh, United Kingdom
  • A. T. Moore
    Molecular Genetics, Institute of Ophthalmology, London, United Kingdom
    Moorfields Eye Hospital, London, United Kingdom
  • Footnotes
    Commercial Relationships  R.H. Henderson, None; K.A. Williamson, None; J. Kennedy, None; A.G. Robson, None; G.E. Holder, None; D.R. FitzPatrick, None; V. van Heyningen, None; A.T. Moore, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2311. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. H. Henderson, K. A. Williamson, J. Kennedy, A. G. Robson, G. E. Holder, D. R. FitzPatrick, V. van Heyningen, A. T. Moore; A Rare De Novo Nonsense Mutation in Otx2 Causes Early Onset Rod-Cone Dystrophy and Pituitary Dysfunction. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2311.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe the clinical findings of a patient with an early onset retinal dystrophy and a novel mutation in OTX2, and contrast these findings with previously reported cases.

Methods: : A panel of 142 patients with a diagnosis of Leber congenital amaurosis (LCA) or early onset retinal dystrophy (EORD) was screened by direct sequencing for mutations in OTX2. All patients had a detailed ophthalmic examination including full field electroretinography (ERG), and retinal imaging.

Results: : Only one mutation in OTX2 was identified. A novel heterozygous S138X stop mutation was identified in a 7 year old male with an infantile onset retinal dystrophy. The mutation was not present in either parent. There was a history of failure to thrive in infancy, poor feeding, and growth hormone deficiency. Poor vision and nyctalopia were present from the first year of life. Fundoscopy revealed a hyperpigmented peripapillary ring with a fine granular pigmentation of the RPE throughout the fundus. The dark adapted bright flash ERG had an electronegative waveform and photopic ERGs had a low b:a ratio. The ERGs were thus consistent with generalized rod and cone system dysfunction at a level that was primarily post-phototransduction or inner retinal. Visual function has remained stable to date.

Conclusions: : Mutations in OTX2 have been reported in association with major developmental malformations of the eye and retinal dystrophies such as LCA. This case adds further support for a role of OTX2 in retinal development and highlights a further retinal dystrophy phenotype seen in association with mutations in OTX2.

Keywords: retinal degenerations: hereditary • genetics • development 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×